Emergent BioSolutions
EBS
#6766
Rank
C$0.87 B
Marketcap
C$16.44
Share price
-1.24%
Change (1 day)
27.67%
Change (1 year)

Emergent BioSolutions (EBS) - Net assets

Net assets on the balance sheet as of September 2025 : C$0.80 Billion

According to Emergent BioSolutions 's latest financial reports the company has C$0.80 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Emergent BioSolutions - Net assets on balance sheet (from 2004 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$C$0.69 B-19.55%
2023-12-31$C$0.86 B-54.27%
2022-12-31$C$1.88 B-8.31%
2021-12-31$C$2.05 B11.31%
2020-12-31$C$1.84 B29.78%
2019-12-31$C$1.42 B3.24%
2018-12-31$C$1.37 B20.06%
2017-12-31$C$1.14 B43.16%
2016-12-31$C$0.80 B-12.49%
2015-12-31$C$0.91 B42.62%
2014-12-31$C$0.64 B23.29%
2013-12-31$C$0.52 B18.44%
2012-12-31$C$0.43 B3.72%
2011-12-31$C$0.42 B13.52%
2010-12-31$C$0.37 B45.56%
2009-12-31$C$0.25 B5.84%
2008-12-31$C$0.24 B41.96%
2007-12-31$C$0.17 B5.91%
2006-12-31$C$0.16 B131.81%
2005-12-31$C$69.54 M152.32%
2004-12-31$C$27.56 M
2002-12-31$C$6.56 M-112.76%
2001-12-31$-C$51.45 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Merck
MRK
C$71.70 B 8,811.07%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
C$0.28 B-65.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$29.25 B 3,535.36%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
C$0.82 B 2.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$128.61 B 15,882.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$10.02 B 1,145.32%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
C$10.49 M-98.70%๐Ÿ‡บ๐Ÿ‡ธ USA